16 news items
Candel Therapeutics' (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers
CADL
7 Jun 24
and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those
Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer
CADL
3 Jun 24
and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
AEI
AKAN
AKTS
24 May 24
This Basic Materials Stock Is ‘Too Dicey,’ Shares His Take On Arista Networks
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting
CADL
23 May 24
to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
AZN
CADL
LTRN
23 May 24
that all material, including this article, which is disseminated by MIQ has been approved by Oncolytics Biotech Inc.; this is a paid advertisement, we
1vs80badv8d97ihb627ic8wpdpqa7h
AZN
CADL
LTRN
23 May 24
material, including this article, which is disseminated by MIQ has been approved by Oncolytics Biotech Inc.; this is a paid advertisement, we
k0qb2 1ztvwq17wpvprv41lt
CADL
20 May 24
and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements
wd73bnz2362e1 o1
ABVC
AMGN
CADL
15 May 24
, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been
hq4nbhozbo8tjcdou t07l
ABVC
AMGN
CADL
15 May 24
notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been
78gz3zwp
AZN
CADL
HALO
9 May 24
provide compelling proof-of-concept for the TRACTr platform in a setting where many other approaches have failed due to material safety issues or lack
5twy7rawuy8so oozaynxnzapf4funjf7lxtcdxdofe3mfnao8ik
AZN
CADL
HALO
9 May 24
data provide compelling proof-of-concept for the TRACTr platform in a setting where many other approaches have failed due to material safety issues
euhziqm4rr9qjq222j26r 08lawkdk05z2ll
AZN
CADL
HALO
9 May 24
for the TRACTr platform in a setting where many other approaches have failed due to material safety issues or lack of efficacy," said
oanl 8rga3tir
AZN
CADL
HALO
9 May 24
for the TRACTr platform in a setting where many other approaches have failed due to material safety issues or lack of efficacy," said
nw46271sz0xsv7c1gx6lvfotqfj pb
CADL
9 Apr 24
to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any
nuv3wxgbon6ceql8tntidt502bajos752r
CADL
28 Mar 24
or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without
o4x5dz62ww3ai2h2wuv02q1vr6w3465mhbreljap4of0mdcoes3dzg5ro65
CADL
15 Mar 24
or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without
- Prev
- 1
- Next